Robert T. Gampe
GlaxoSmithKline (United States) · 87 works · 4,608 citations · h-index 25
Top works
- Asymmetry in the PPARγ/RXRα Crystal Structure Reveals the Molecular Basis of Heterodimerization among Nuclear Receptors
- Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors
- NMR studies of [U-13C] cyclosporin A bound to cyclophilin: bound conformation and portions of cyclosporin involved in binding
- Oxindole-Based Inhibitors of Cyclin-Dependent Kinase 2 (CDK2): Design, Synthesis, Enzymatic Activities, and X-ray Crystallographic Analysis
- Accounting for spin diffusion in the analysis of 2D NOE data
- Discovery of 7-Methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1 H -indol-5-yl)-7 H -pyrrolo[2,3- d ]pyrimidin-4-amine (GSK2606414), a Potent and Selective First-in-Class Inhibitor of Protein Kinase R (PKR)-like Endoplasmic Reticulum Kinase (PERK)
- Heteronuclear three-dimensional NMR spectroscopy. Natural abundance carbon-13 chemical shift editing of 1H-1H COSY spectra
- Isotope-Edited NMR of Cyclosporin a Bound to Cyclophilin: Evidence for a Trans 9,10 Amide Bond
- Prevention of Chemotherapy-Induced Alopecia in Rats by CDK Inhibitors
- Structural Basis for Androgen Receptor Interdomain and Coactivator Interactions Suggests a Transition in Nuclear Receptor Activation Function Dominance
- Determining the structure of a glycopeptide Ac2-Lys-D-Ala-D-Ala complex using NMR parameters and molecular modeling
- Application of isotope-filtered 2D NOE experiments in the conformational analysis of atrial natriuretic factor(7–23)
- NMR studies of an FK-506 analog [U-13C]ascomycin, bound to FKBP: conformation and regions of ascomycin involved in binding
- Structural basis for autorepression of retinoid X receptor by tetramer formation and the AF-2 helix
- Modulation of Androgen Receptor Activation Function 2 by Testosterone and Dihydrotestosterone
- Solution Structure of the Human pp60c-src SH2 Domain Complexed with a Phosphorylated Tyrosine Pentapeptide
- Discovery of GSK2656157: An Optimized PERK Inhibitor Selected for Preclinical Development
- Two‐Dimensional NMR studies of [Pro‐10] atrial natriuretic factor [7‐23]
- Crystallization of protein–ligand complexes
- Heteronuclear three-dimensional NMR spectroscopy applied to CMP-KDO synthetase (27.5 kD)